Work

Abstract 2858: Development of a first-in-class humanized antibody targeting CXCL1 in bladder cancer

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2022-2858

Authors: Kaoru Murakami, Yuka Sasaki, Hideki Furuya, Charles Rosser

Institution: Cedars-Sinai Medical Center

Language: English

Topic: Chemokine receptors and signaling

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282971086

Cites:

Cited by: 3

Related to: 10